Samrat Pharmachem Limited Share Price

Equities

SAMRATPH6

INE103E01016

Pharmaceuticals

Market Closed - Bombay S.E. 09:42:00 03/07/2024 am IST 5-day change 1st Jan Change
342 INR +0.32% Intraday chart for Samrat Pharmachem Limited +0.71% -1.78%
Sales 2022 221.92Cr 2.66Cr Sales 2023 310.74Cr 3.72Cr Capitalization 114.66Cr 1.37Cr
Net income 2022 17Cr 20.6L Net income 2023 17Cr 19.88L EV / Sales 2022 0.63 x
Net cash position 2022 9.76Cr 11.68L Net Debt 2023 6.78Cr 8L EV / Sales 2023 0.39 x
P/E ratio 2022
8.72 x
P/E ratio 2023
6.89 x
Employees 29
Yield 2022
0.21%
Yield 2023
0.27%
Free-Float 42.41%
More Fundamentals * Assessed data
Dynamic Chart
Crisil Gives BB+ Rating to Samrat Pharmachem's Bank Loans; Outlook Stable MT
Samrat Pharmachem Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Samrat Pharmachem Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Samrat Pharmachem Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Samrat Pharmachem Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Samrat Pharmachem Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
Samrat Pharmachem Limited Recommends Dividend for the Financial Year Ended March 31, 2023 CI
Samrat Pharmachem Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Samrat Pharmachem Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Samrat Pharmachem Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022 CI
Samrat Pharmachem Limited Recommends Dividend for the Financial Year Ended March 31, 2022 CI
Samrat Pharmachem Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Samrat Pharmachem Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Samrat Pharmachem Limited Reports Earnings Results for the First Quarter Ended June 30, 2021 CI
Samrat Pharmachem Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021 CI
More news
1 day+0.32%
1 week+0.71%
Current month+0.97%
1 month-5.60%
3 months-9.64%
6 months-10.31%
Current year-1.78%
More quotes
1 week
331.10
Extreme 331.1
354.00
1 month
330.00
Extreme 330
372.60
Current year
320.00
Extreme 320
459.00
1 year
320.00
Extreme 320
533.60
3 years
170.00
Extreme 170
1 250.00
5 years
47.10
Extreme 47.1
1 250.00
10 years
20.10
Extreme 20.1
1 250.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 87 16/92/16
Director of Finance/CFO 60 16/92/16
Compliance Officer - 22/20/22
Members of the board TitleAgeSince
Director of Finance/CFO 60 16/92/16
Chief Executive Officer 87 16/92/16
Director/Board Member 60 17/03/17
More insiders
Date Price Change Volume
03/24/03 342 +0.32% 207
02/24/02 340.9 -2.45% 4,438
01/24/01 349.4 +3.17% 3,228
28/24/28 338.7 +0.24% 1,835
27/24/27 337.9 -0.50% 1,763

Delayed Quote Bombay S.E., July 03, 2024 at 09:42 am IST

More quotes
Samrat Pharmachem Limited is an India-based company, which is engaged in the manufacturing and selling of pharmaceutical chemicals. The Company is a supplier of iodine derivatives to the Indian and foreign market. The Company’s products include 3-5-Di Iodosalicylic Acid, Ammonium Iodide, Calcium Iodide, Clioquinol, Copper Iodide, Ethyl Iodide, Ethylenediamine Dihydroiodide, Hydroiodic Acid 57%, Iodic Acid, Iodine, Iodine Monochloride, Iodoquinol, Lithium Iodide, Methyl Iodide, N-Iodo Succcinimide, Periodic Acid, Potassium Iodate, Potassium Iodide, Potassium Metaper Iodate, Povidone Iodine, Selenium Dioxide, Sodium Iodate, Sodium Iodide, Sodium Metaper Iodate, Sodium Selenite, Tetra Butyl Ammonium Iodide, and Tri Methyl Sulphoxonium Iodide. It serves various industries, such as agrochemical, animal feed, chemicals, food, pharmaceutical, printing, and textile. The Company exports its products to various countries, including United States, Europe, Africa, Asia, and Middle East.
More about the company
  1. Stock Market
  2. Equities
  3. SAMRATPH6 Stock